← Mechanisms of action
Dopamine receptor
PROTEIN FAMILYHomo sapiens
Linked proteins
Drugs acting on this target (16)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| fencamfamine | Activator | experimental | Small molecule | Dopamine receptor activator |
| mescaline | Activator | experimental | Small molecule | Dopamine receptor activator |
| deoxyadrenaline | Agonist | experimental | Small molecule | Dopamine receptor agonist |
| dopexamine | Agonist | experimental | Small molecule | Dopamine receptor agonist |
| ergoloid mesylate | Agonist | approved | Small molecule | Dopamine receptor agonist |
| foscarbidopa | Agonist | approved | Small molecule | Dopamine receptor agonist |
| foslevodopa (VYALEV) | Agonist | approved | Small molecule | Dopamine receptor agonist |
| lisuride (Dopergin) | Agonist | experimental | Small molecule | Dopamine receptor agonist |
| melevodopa | Agonist | experimental | Small molecule | Dopamine receptor agonist |
| pergolide (permax) | Agonist | approved | Small molecule | Dopamine receptor agonist |
| xp21279 | Agonist | experimental | Small molecule | Dopamine receptor agonist |
| amoxapine (asendin) | Antagonist | approved | Small molecule | Dopamine receptor antagonist |
| pimozide (orap) | Antagonist | approved | Small molecule | Dopamine receptor antagonist |
| vk4-116 | Antagonist | experimental | Small molecule | Dopamine receptor antagonist |
| sulpiride | Inhibitor | experimental | Small molecule | Dopamine receptor inhibitor |
| Tavapadon | Partial agonist | experimental | Small molecule | Dopamine receptor partial agonist |